GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » 5-Year Yield-on-Cost %

HLS Therapeutics (HLS Therapeutics) 5-Year Yield-on-Cost % : 1.74 (As of May. 01, 2024)


View and export this data going back to 2010. Start your Free Trial

What is HLS Therapeutics 5-Year Yield-on-Cost %?

HLS Therapeutics's yield on cost for the quarter that ended in Dec. 2023 was 1.74.


The historical rank and industry rank for HLS Therapeutics's 5-Year Yield-on-Cost % or its related term are showing as below:

HLTRF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.53   Med: 3.39   Max: 25.97
Current: 1.74


During the past 13 years, HLS Therapeutics's highest Yield on Cost was 25.97. The lowest was 0.53. And the median was 3.39.


HLTRF's 5-Year Yield-on-Cost % is ranked worse than
57.2% of 500 companies
in the Drug Manufacturers industry
Industry Median: 2.175 vs HLTRF: 1.74

Competitive Comparison of HLS Therapeutics's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, HLS Therapeutics's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLS Therapeutics's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HLS Therapeutics's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where HLS Therapeutics's 5-Year Yield-on-Cost % falls into.



HLS Therapeutics 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of HLS Therapeutics is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

HLS Therapeutics  (OTCPK:HLTRF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


HLS Therapeutics 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


HLS Therapeutics (HLS Therapeutics) Business Description

Traded in Other Exchanges
Address
10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W6L2
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.

HLS Therapeutics (HLS Therapeutics) Headlines

From GuruFocus

Automodular Corp. (TSX:AM) - Strong Buy

By Elliot Luchansky, CFA Elliot Luchansky, CFA 03-21-2013